TaiChi and Qigong for Depressive Symptoms in Patients with Chronic Heart Failure: A Systematic Review with Meta-Analysis

Background. Depression is a debilitating comorbidity of heart failure (HF) that needs assessment and management. Along with mind-body exercise to deal with HF with depression, the use of TaiChi and/or Qigong practices (TQPs) has increased. Therefore, this systematic review assesses the effects of TQPs on depression among patients with HF. Methods. Randomized controlled trials (RCTs) that examined the effect of TQPs on depression in patients with HF were searched by five databases (PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, CINAHL, and China National Knowledge Infrastructure (CNKI)). With standardized mean difference (SMD) and 95% confidence intervals (95% CI), random-effects meta-analyses of the effect of TQPs on depressive symptoms were performed. Results. Of eight included RCTs, seven (481 patients) provided data for the meta-analysis. The pooling revealed that TQPs contribute to depression remission in HF (SMD −0.66; 95% CI −0.98 to −0.33, P < 0.0001 ; I2 = 64%). Its antidepressive effect was not influenced by intervention duration or exercise setting, but rather by ejection fraction subtype, depressive severity, and depression instruments. The beneficial effects were preserved when the study with the largest effect was removed. Conclusion. This study suggests that TQPs might be a good strategy for alleviating depressive symptoms in patients with HF. And rigorous-design RCTs, which focus on the identified research gaps, are needed to further establish the therapeutic effects of TQPs for depression in HF.

Download Full-text

Tai Chi and other mind–body interventions for cancer-related fatigue: an updated systematic review and network meta-analyses protocol

BMJ Open ◽

10.1136/bmjopen-2021-052137 ◽

2022 ◽

Vol 12 (1) ◽

pp. e052137

Author(s):

Hong-Juan Fu ◽

Hao Zhou ◽

Yong Tang ◽

Jie Li ◽

Da Zhang ◽

...

Keyword(s):

Systematic Review ◽

Evaluation System ◽

Tai Chi ◽

Evidence Base ◽

Controlled Trials ◽

Cochrane Central Register ◽

China National Knowledge Infrastructure ◽

Cancer Related Fatigue ◽

Meta Analyses

IntroductionFatigue is one of the most common symptoms in patients with cancer and is responsible for a reduced quality of life. There is a strong evidence base for mind–body interventions (MBIs) to manage cancer-related fatigue (CRF). However, the efficacy of Tai Chi and other MBIs in the treatment of CRF remains controversial.Methods and analysisWe will perform a systematic review and network meta-analyses (NMAs) that aim to assess the effects of Tai Chi and other MBIs in patients with CRF. The following databases will be searched from their inception to 1 August 2021: PubMed, EMBASE, Scopus, OVID, Web of Science, Cochrane Central Register of Controlled Trials, the China National Knowledge Infrastructure, China Science and Technology Journal Database, Chinese Biomedical Database and Wan Fang Digital Journals. We will include randomised controlled trials that compare MBIs with no treatment, placebo and usual care in the treatment of CRF. The primary outcome will be changes in the fatigue state as evaluated by validated scales. We will perform a Bayesian NMA to analyse all the evidence for each outcome. The surface under the cumulative ranking curve and the mean ranks will be used to rank the various treatments. We will assess the quality of evidence contributing to network estimates of outcomes using the Grading of Recommendations Assessment, Development and Evaluation system framework.Ethics and disseminationThis NMAs will be disseminated through publication in a peer-reviewed journal. Since no individual patient data will be involved in the review, ethics approval and concerns about privacy are not needed.PROSPERO registration numberCRD42021244999.

Download Full-text

Buteyko method for people with asthma: a protocol for a systematic review and meta-analysis

BMJ Open ◽

10.1136/bmjopen-2021-049213 ◽

2021 ◽

Vol 11 (10) ◽

pp. e049213

Author(s):

Karla Morganna Pereira Pinto de Mendonça ◽

Sean Collins ◽

Tácito ZM Santos ◽

Gabriela Chaves ◽

Sarah Leite ◽

...

Keyword(s):

Systematic Review ◽

Systematic Reviews ◽

Meta Analysis ◽

Secondary Data ◽

Controlled Trials ◽

Cochrane Central Register ◽

Plain Language ◽

Randomised Controlled ◽

Meta Analyses

IntroductionButeyko method is recommended as a non-pharmacological treatment for people with asthma. Although the worldwide interest in the Buteyko method, there is a paucity of studies gathering evidence to support its use. Therefore, we aim to conduct a systematic review and meta-analysis to assess the effects of the Buteyko method in children and adults with asthma.Methods and analysisWe will search on Cochrane Central Register of Controlled Trials, MEDLINE, Embase, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov and WHO International Clinical Trials Registry Platform for studies focusing on the Buteyko method for children and adults with asthma. The searches will be carried out in September 2021 from database’s inception to the present. We will include randomised controlled trials comparing Buteyko method alone with asthma education or inactive control intervention. There will be no restriction on language. Primary outcomes include quality of life, asthma symptoms and adverse events/side effects. Two review authors will independently screen the studies for inclusion and extract data. We will assess the quality of the included studies using the ‘Risk of Bias’ tool. The certainty of the evidence will be assessed using the GRADE approach. Data synthesis will be conducted using Review Manager software. Reporting of the review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance and the Cochrane Handbook for Systematic Reviews of Interventions.Ethics and disseminationThis study will assess and provide evidence for the use of the Buteyko method in people with asthma. We will analyse secondary data and this does not require ethics approval. The findings will be published in peer-reviewed journals, at relevant conferences and will be shared in plain language in social media. Moreover, the findings of this review could guide the direction of healthcare practice and research.PROSPERO registration numberCRD42020193132.

Download Full-text

A Systematic Review and Meta-Analysis of Local Administration of 1 Percent Metformin as an Adjunct to Scaling and Root Planning on Periodontal Intrabony Defects

Journal of Dentistry and Oral Sciences ◽

10.37191/mapsci-2582-3736-2(4)-053 ◽

2020 ◽

Author(s):

Hussam M. Alqahtani

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Local Administration ◽

Controlled Trials ◽

Cochrane Central Register ◽

Scaling And Root Planing ◽

Intrabony Defects ◽

Intrabony Defect ◽

Root Planing ◽

Meta Analyses

The Purpose: This systematic review conducted to assess the effectiveness of local administration of 1 % Metformin as an adjunct to scaling and root planing on periodontal intrabony defects. Methods: Two independents reviewers searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and ClinicalTrials.gov.We included randomized controlled trials (RCTs) of local administration of 1% metformin interventions in patients with periodontal intrabony defect undergoing scaling and root planing as compared to local administration of placebo gel where periodontal parameters were evaluated. The Cochrane RoB tool was used to evaluate the risk of bias. Meta-analyses for the quantitative data were performed. We assessed the level of certainty for our outcomes using (GRADE) tool. Results: Among the 1666 studies screened, two RCTs were included in the meta-analyses. The meta-analysis showed a statistically significant difference for all outcomes except the plaque index.Quantitative analyses showed a weighted mean difference (WMD) of1.17 mm (95% CI=1.01 to 1.34 mm, P<0.00001) for depth of periodontal intrabony defect; a WMD of 2.54 mm (95% CI=2.20 to 2.88 mm, P<0.00001) for clinical attachment level;a WMD of 2.01 mm (95%CI=1.68 to 2.33 mm, P<0.00001) for probing depth (PD);a WMD of 0.38 (95% CI=0.14 to 0.62, P = 0.002) for bleeding on probing (BOP); and a WMD of 0.00 mm (95% CI=−0.04 to 0.04 mm, P=0.95) for plaque index. There is moderate certainty of the evidence for all outcomes. Conclusions: Local application of 1% metformin in patients with periodontal intrabony defect may improve the clinical and radiographic periodontal parameters. Future clinical trials are required to confirm the clinical benefits of a 1% metformin application as adjunctive to scaling and root planing in patients with periodontal intrabony defect. Trial Registration: International Prospective Register of Systematic Reviews (PROSPERO): CRD167223.

Download Full-text

Effectiveness of remineralising agents in prevention and treatment of orthodontically induced white spot lesions: a protocol for a systematic review incorporating network meta-analysis

Systematic Reviews ◽

10.1186/s13643-019-1253-8 ◽

2019 ◽

Vol 8 (1) ◽

Cited By ~ 1

Author(s):

Huimin Hu ◽

Chong Feng ◽

Zhaowei Jiang ◽

Lufei Wang ◽

Sonu Shrestha ◽

...

Keyword(s):

Systematic Review ◽

Adverse Effects ◽

Meta Analysis ◽

White Spot ◽

Orthodontic Appliances ◽

Controlled Trials ◽

Cochrane Central Register ◽

White Spot Lesions ◽

Prevention And Treatment ◽

Meta Analyses

Abstract Background White spot lesions (WSLs) are common adverse effects in fixed orthodontic treatment. Remineralising agents are widely used to prevent WSLs formation and are the first-line treatment for existing WSLs. Previous systematic reviews have evaluated the effectiveness of remineralisation agents in the management of WSLs. However, their conclusions were contradictory. The objective of this study will be to compare the effectiveness and safety of current remineralising agents used in the management of WSLs in patients treated with fixed orthodontic appliances in any orthodontic setting. Methods Literature searches will be conducted in several electronic databases (from inception onwards): MEDLINE (via Ovid), Scopus, Embase, the Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL), among others. Grey literature will be identified through searching clinical trials registries. Randomised controlled trials that compared the effectiveness of different remineralisation agents in the prevention and treatment of WSLs will be included. Two researchers will independently screen all citations, full-text articles, and abstract data. The study risk bias will be appraised using an appropriate tool. The primary outcomes will be WSLs incidence and severity of WSLs. Secondary outcomes will be subjective measures of WSLs and adverse effects. The mean difference (MD) and relative risk (RR) with corresponding 95% confidence intervals (CI) will be chosen as effect measures for continuous and binary outcomes, respectively. If feasible, fixed and random-effects pairwise meta-analyses and frequentist network meta-analyses will be conducted where appropriate. Discussion This network meta-analysis will compare the effectiveness of remineralising agents in the prevention and treatment of orthodontically induced WSLs. By integrating the evidence from direct and indirect comparisons and ranking all evaluated interventions, our findings have the potential to help clinicians make more accurate treatment decisions. Systematic review registration PROSPERO CRD42019116852, registered on March 15, 2019

Download Full-text

Effectiveness of Acupuncture for Poststroke Aphasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Complementary Medicine Research ◽

10.1159/000512672 ◽

2021 ◽

pp. 1-11

Author(s):

Yu Zhang ◽

Zhijie Wang ◽

Xudong Jiang ◽

Zimeng Lv ◽

Lin Wang ◽

...

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Reading Ability ◽

Meta Analysis ◽

Reporting Quality ◽

Cochrane Library ◽

Controlled Trials ◽

Therapeutic Effects ◽

China National Knowledge Infrastructure ◽

Randomized Controlled

Background: Aphasia is one of the common complications of stroke, and it considerably influences the quality of life of patients. Acupuncture, a therapy used in traditional Chinese medicine for aphasia after stroke, has potential therapeutic effects. We aimed to investigate the therapeutic effect of acupuncture on individuals with poststroke aphasia. Methods: Randomized controlled trials (RCTs) on acupuncture for poststroke aphasia (either alone or combined with other therapies) were included and compared. We conducted a systematic review and meta-analysis by searching databases, such as MEDLINE, Cochrane Library, Embase, China National Knowledge Infrastructure, VIP, and Wanfang, from inception to July 15, 2019. No language restrictions were applied in this study. Results: Fourteen trials involving 936 participants had poor reporting and methodological quality. Our meta-analysis showed that compared to the speech and language therapy (SLT) group, acupuncture combined with SLT could improve the rate of Boston Diagnostic Aphasia Examination (BDAE) (OR: 0.15, 95% confidence interval [CI]: 0.04–0.25, p = 0.005), scores of Aphasia Battery of Chinese (ABC) which includes repeating ability (SMD: 1.46, 95% CI: 1.24–1.69, p < 0.00001), reading ability (SMD: 1.57, 95% CI: 1.25–1.90, p < 0.00001), writing ability (SMD: 1.52, 95% CI: 1.19–1.86, p < 0.00001), naming ability (SMD: 1.40, 95% CI: 1.04–1.76, p < 0.00001), and listening comprehension ability (SMD: 0.57, 95% CI: 0.22–0.92, p = 0.001). All RCTs were considered at high risk of biased assessment. Conclusions: Acupuncture (either alone or combined with SLT) may be effective for poststroke aphasia. In the future, rigorous clinical trials with an accurate method design and high reporting quality are required to validate our results.

Download Full-text

Efficacy of Mhealth Interventions to Improve Nasal Corticosteroid Adherence in Allergic Rhinitis: A Systematic Review Protocol

10.21203/rs.3.rs-277478/v1 ◽

2021 ◽

Author(s):

Mats Baxter ◽

Jurgen Schwarze ◽

Andrew Bush ◽

Aziz Sheikh

Keyword(s):

Systematic Review ◽

Allergic Rhinitis ◽

Meta Analysis ◽

Risk Of Bias ◽

Controlled Trials ◽

Cochrane Central Register ◽

Systematic Review Protocol ◽

Review Protocol ◽

Randomised Controlled ◽

Meta Analyses

Abstract IntroductionMobile health (mHealth) is a potential tool to improve nasal corticosteroid (NCS) adherence in allergic rhinitis (AR), which remains largely poor and inconsistent for many. We plan to undertake a systematic review to synthesise the evidence on the efficacy of mHealth interventions to improve NCS adherence in AR. Methods and analysisA systematic search will be conducted in the electronic databases MEDLINE, EMBASE and CENTRAL (Cochrane Central Register of Controlled Trials), filtered for publication dates between January 2010 and August 2020. The search is scheduled to commence in August 2020. We will scan reference lists of included studies for additional eligible papers. Relevant unpublished or in-progress trials will be searched for through trial registries. Randomised controlled trials that examine the efficacy of mHealth interventions to improve NCS adherence in AR are to be included. Two reviewers will independently screen and extract relevant data from the included studies and perform a risk-of-bias assessment using the Cochrane risk of bias tool 2.0. We will perform a narrative synthesis with relevant data tables and, if deemed clinically relevant and statistically adequate, meta-analyses using random-effects modelling. The Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA) statement will be used to help guide the reporting of this review. Ethics and disseminationSince this systematic review will be exclusively based on published and retrievable literature, no ethics approval will be sought. The findings of this systematic review will be disseminated at appropriate conferences/webinars while being published in an open access peer-reviewed journal.Registration: In accordance with the guidelines, our systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 27th August 2020. PROSPERO registration number CRD42020198879.

Download Full-text

Efficacy of mobilisation with movement in chronic shoulder pain: protocol for a systematic review and meta-analysis of controlled trials

BMJ Open ◽

10.1136/bmjopen-2021-049563 ◽

2021 ◽

Vol 11 (8) ◽

pp. e049563

Author(s):

Arnstein Storås ◽

Fabian Lillebostad ◽

Sturla Haslerud ◽

Jon Joensen ◽

Jan Magnus Bjordal ◽

...

Keyword(s):

Systematic Review ◽

Shoulder Pain ◽

Controlled Trial ◽

Meta Analysis ◽

Controlled Trials ◽

Cochrane Central Register ◽

Musculoskeletal Problems ◽

Evidence Database ◽

Meta Analyses ◽

Chronic Shoulder Pain

IntroductionShoulder pain affects approximately one in four adults and is thus one of the most common musculoskeletal problems. Only 50% of patients who begin treatment for shoulder pain are cured within 6 months. There is a need for systematic reviews to estimate the effectiveness of shoulder treatments. We decided to evaluate the effect of mobilisation with movement (MWM) on chronic shoulder pain in a systematic review.Methods and analysisThe review will include controlled trial articles identified via five electronic databases (PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, Physiotherapy Evidence Database and Cochrane Central Register of Controlled Trials), reference lists, citations searches and experts in the field. Only controlled trials involving participants with a mean duration of pain of ≥3 months, in which the effectiveness of MWM has been compared with non-invasive treatments, sham mobilisation or wait-and-see will be included. The included trials will be synthesised with random effects meta-analyses. Risk-of-bias will be assessed with the Physiotherapy Evidence Database 0–10 point scale.Ethics and disseminationThe review does not require ethics approval as it is based on anonymised data from trial reports. The results of the review will be disseminated through a peer-reviewed publication.PROSPERO registration numberCRD42018109380.

Download Full-text

eHealth interventions for reducing cardiovascular disease risk in men: a systematic review and meta-analysis

European Journal of Cardiovascular Nursing ◽

10.1093/eurjcn/zvab060.059 ◽

2021 ◽

Vol 20 (Supplement_1) ◽

Author(s):

J Mcmahon ◽

DR Thompson ◽

MC Pascoe ◽

K Brazil ◽

CF Ski

Keyword(s):

Systematic Review ◽

Cardiovascular Disease ◽

Behavior Change ◽

Systematic Reviews ◽

Meta Analysis ◽

Database Search ◽

Controlled Trials ◽

Cochrane Central Register ◽

Cvd Risk ◽

Meta Analyses

Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Department for the Economy (DfE) studentships Background. Men remain at a higher risk of developing cardiovascular disease (CVD) than women and behavioral risk factor modification is an important preventive measure. However, engaging men in behavior change interventions is challenging. eHealth interventions have the potential to address this gap, though their effectiveness for reducing CVD risk in men is unclear. Purpose. To conduct a systematic review and meta-analysis to evaluate the effectiveness of eHealth interventions for reducing CVD risk in men. Methods. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and principles laid out by the Cochrane Handbook for Systematic Reviews of Interventions. A search of published randomised controlled trials (RCTs) with no date restrictions up to July 2020 was conducted across five electronic databases: Cochrane Central register of Controlled Trials (CENTRAL), Medline, CINAHL Plus, PsycINFO and SCOPUS. Reference lists of relevant systematic reviews and meta-analyses were manually searched for additional trials not identified during the database search. Eligible studies were RCTs that focused on the use of eHealth to improve a minimum of two major CVD related risk factors in males aged 18 years or older. Results. A total of 3168 records were retrieved from the online database search, with nine trials meeting the inclusion criteria following screening and full-text assessment. Study quality ranged from low to unclear, with one trial at a high risk of bias. Compared to those in a control group or receiving printed materials, participants randomised to an eHealth intervention had statistically significant improvements in BMI (Z=-2.75, p = 0.01), body weight (Z=-3.25, p = 0.01), waist circumference (Z=-2.30, p = 0.02) and systolic (Z=-3.57, p = 0.01) and diastolic (Z=-3.56, p = 0.01) blood pressure. Though less evident, there were also improvements in physical activity and diet in favour of the intervention group. Conclusion. This was the first systematic review and meta-analysis conducted on the effectiveness of eHealth interventions for reducing CVD risk in men. This review suggests that eHealth interventions can reduce CVD risk in adult men through behavior change. However, we were unable to determine the association between intervention characteristics and outcomes. Also, overall, participant adherence to the intervention was poor. Both of these issues should be considered in future studies.

Download Full-text

Resilience Programs for Children and Adolescents: A Systematic Review and Meta-Analysis

Frontiers in Psychology ◽

10.3389/fpsyg.2021.754115 ◽

2021 ◽

Vol 12 ◽

Author(s):

Tatiana Matheus Pinto ◽

Paulo Guirro Laurence ◽

Cristiane Rufino Macedo ◽

Elizeu Coutinho Macedo

Keyword(s):

Systematic Review ◽

Program Effectiveness ◽

Meta Analysis ◽

Controlled Trials ◽

Childhood And Adolescence ◽

Cochrane Central Register ◽

Clinical Trial Registration ◽

Treatment As Usual ◽

Meta Analyses

Resilience may be defined as the ability to recover and adapt to adverse situations. Given that resilience involves cognitive and behavioral aspects, it could be promoted based on strategies that favor them, especially during childhood and adolescence. As a result, several resilience-focused programs have been developed and studied. This systematic review of Randomized Controlled Trials (RCTs) aimed to assess resilience-focused programs for children (<12 years old) and adolescents (12–22 years old) compared to active (treatment as usual, other program modalities, and educational curriculum at school) or inactive (waiting list, no treatment) control groups. We performed a systematic review of meta-analyses of RCTs. The following databases were searched: Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, and PsycINFO. Two authors independently selected the studies, extracted the data, and assessed the studies’ risk of bias. Meta-analyses of random effects were conducted to calculate the standard mean differences (SMD) and 95% confidence interval (CI) of program effectiveness. Of the 17 RCTs that met the inclusion criteria, 13 provided sufficient data to assess the effectiveness of the programs after their implementation. Meta-analyses indicated overall effectiveness of the programs in promoting resilience (SMD = 0.48, 95% CI [0.15, 0.81], p = 0.0077). The subgroup analysis indicated effectiveness only among adolescents’ resilience (SMD = 0.48, 95% CI [0.08, 0.88], p = 0.02). The follow-up analysis also indicated evidence of continuation of results within a period of up to 6 months up (SMD = 0.12, 95% CI [−0.44, 0.69], p = 0.02). These results indicated the effectiveness of promoting resilience, especially in adolescents, and its continuation in follow-up analyses. These findings are promising in the field of resilience programs; however, further studies are necessary to analyze the different possible characteristics of programs and their results.Clinical Trial Registration: [https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020179874], [CRD42020179874].

Download Full-text

Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis

CNS & Neurological Disorders - Drug Targets ◽

10.2174/1871527317666181105162347 ◽

2019 ◽

Vol 18 (1) ◽

pp. 19-28 ◽

Cited By ~ 6

Author(s):

Daniela V. Bavaresco ◽

Tamy Colonetti ◽

Antônio J. Grande ◽

Francesc Colom ◽

Samira S. Valvassori ◽

...

Keyword(s):

Systematic Review ◽

Bipolar Disorder ◽

Adjuvant Treatment ◽

Meta Analysis ◽

Controlled Trials ◽

Therapeutic Effects ◽

Cochrane Central Register ◽

Adjunct Treatment ◽

Registration Number ◽

Cox 2

Background: Bipolar Disorder (BD) is a psychiatric disorder characterized by mood disturbances. The pathophysiology of BD is still poorly understood. In the last years, research studies focused on the role of inflammation in BD. Objective: Performed a systematic review and meta-analysis to evaluate the potential effect of the cyclo- oxygenases (Cox)-2 inhibitor Celecoxib adjunct treatment in BD through randomized controlled trials (RCT). Methods: A search on the electronic databases was proceeded, on MEDLINE, EMBASE, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), Biomed Central, Web of Science, IBECS, LILACS, PsycINFO, Congress Abstracts, and Grey literature (Google Scholar and the British Library) for studies published from January 1990 to February 2018. A search strategy was developed using the terms: “Bipolar disorder” or “Bipolar mania” or “Bipolar depression” or “Bipolar mixed” or “Bipolar euthymic” and “Celecoxib” or “Cyclooxygenase-2 inhibitors” or “Cox-2 inhibitors” as text words and Medical Subject Headings (i.e., MeSH and EMTREE) and searched. The therapeutic effects of adjunctive treatment with Celecoxib were analyzed. The meta-analysis was performed including the results of the Young Mania Rating Scale (YMRS) at the end of RCT. Results: Three primary studies were included in the systematic review, with a total of 121 patients. The meta-analysis showed a significant effect on the YMRS scores from patients with BD who used Celecoxib adjuvant treatment in comparison to placebo. Conclusion: The systematic review suggests that adjuvant treatment with Celecoxib improves the response of major treatments in patients with BD when compared with adjuvant placebo treatment. Systematic Review Registration Number: The review protocol was registered at PROSPERO (registration number: CRD42017067635); in June 06 2017.

Download Full-text